drugset / Trial / NCT03204123
PSMA PET Imaging of Recurrent Prostate Cancer
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
The purpose of this study is to see if a new diagnostic research agent named 68Ga-HBED-CC-PSMA can show prostate cancer on a PET/CT scan that cannot be seen on other standard imaging even when the PSA levels are very low.
Timeline
- Start
- 2017-06-26
- Primary completion
- 2027-06
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ga-HBED-iPSMA | Unknown | 100 mbq | Other |
| Comparator | Ga-HBED-iPSMA | Unknown | 300 mbq | Other |